CVRx, Inc. - Common Stock, $0.01 par value (CVRX)

CUSIP: 126638105

Q3 2024 13F Holders as of 30 Sep 2024

Holder snapshot 7 signals
Share change
+982,075
Put/Call ratio
74%
SEC-reported price per share
$8.81
Number of holders
84
Value change
+$5,810,039
Number of buys
53
Open additional details 1 more signal available
Number of sells
23
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
26,612,903

Security key

126638105

Report period

Q3 2024

Institutions

84

Top holders

10

Ownership snapshot

Top reported holders of CVRX - CVRx, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Johnson & Johnson Innovat...
Disclosed value leader
Johnson & Johnson Innovat...
Comparable rows
0/15
Latest evidence
30 Jun 2024
3/4/5 13F Highest disclosed value: $64,860,045 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Johnson & Johnson Innovation - JJDC, Inc. has the largest disclosed position value at $64.86M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Johnson & Johnson Innovation - JJDC, Inc.'s linked filing trail.
Disclosed position value Top 5
Johnson & Johnson Innovation - JJ... $64.86M
NEW ENTERPRISE ASSOCIATES 10 L P $37.59M
GSK plc $18.7M
NEA PARTNERS 10 L P $3.22M
JOHNSON & JOHNSON $49.2M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Johnson & Johnson Innovation - JJDC, Inc.
3/4/5
10%+ Owner
—
denominator unverified
$64,860,045
3,495,575 shares
— 15 Sep 2023
NEW ENTERPRISE ASSOCIATES 10 L P
3/4/5
10%+ Owner
—
denominator unverified
$37,593,767
2,026,083 shares
— 02 Jul 2021
GSK plc
3/4/5
10%+ Owner
—
denominator unverified
$18,695,602
1,007,583 shares
— 02 Jul 2021
NEA PARTNERS 10 L P
3/4/5
10%+ Owner
—
denominator unverified
$3,217,197
173,388 shares
— 02 Jul 2021
JOHNSON & JOHNSON
13F
Company
13F
—
denominator unverified
$49,200,126
4,103,430 shares
— 30 Jun 2024
Geoffrey B. Pardo
3/4/5
Director
—
mixed-class rows
$33,990,694
1,839,404 shares
mixed-class rows
— 02 Jul 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
84
Shares
14,208,138
Rows available
84
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
72
Q3 2024 holders
84
Holder diff
12
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .